Sundas Abbas, MD
Hospitalist · Santa Rosa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Providence Medical Foundation · Hospitalist Medicine Physicians of Texas PLLC
Hospitals listed: Ascension Via Christi Hospitals Wichita, Inc.. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Abbas’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Ascension Via Christi Hospitals Wichita, Inc.Wichita, KSAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Ascension Health, which runs 120 hospitals in 13 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.194, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.374, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.248, Oct 2024 – Sep 2025
See every measure and the patient survey for Ascension Via Christi Hospitals Wichita, Inc.
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.194 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.374 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.248 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.78) · 1,726 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.65 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 194.99 (155.44 to 234.55) · 170 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.4 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 280 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.4 · 627 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 452 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.2 · 4,183 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.07 to 0.45) · 9,772 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.47) · 10,223 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.08 (0.38 to 3.77) · 3,062 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.09 (0 to 2.5) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.77 (0.51 to 3.03) · 2,819 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.8 (6.16 to 15.44) · 1,234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.47 to 9.39) · 1,319 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.48 (0.08 to 2.89) · 548 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 0.88) · 8,317 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 61 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.787 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.648 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 559 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -10 · 308 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 16.2 · 499 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.3 · 694 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.4 · 840 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 173 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.7 to 19.1) · 289 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 142 cases | No different | Jan 2024 – Dec 2024 |
What patients said (431 patients answered, 18% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 59% |
| Nurses "always" communicated well | 71% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$63,154
Medicare paid this office $63,154 for 197 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 139 | $39,761 | $86 |
| Hospital discharge day management, more than 30 minutes | 88 | $7,431 | $83 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $7,006 | $123 |
| Critical care, first 30-74 minutes | 24 | $5,743 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,425 | $58 |
Who their Medicare patients are
197 Original Medicare patients in 2024. Average age 76 · Under 65 12% · 85 and older 23% · Women 50% · Also on Medicaid 22% · Health risk score 2.74. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 65% · Chronic kidney disease 57% · Diabetes 51% · Atrial fibrillation 50% · Heart failure 49% · Depression 45% · COPD 33% · Stroke 29% · Dementia 21% · Cancer 14%.
The office billed $561,784, Medicare allowed $80,045 and paid $63,154; for 699 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 197 | 699 | 76 | 2.74 | $561,784 | $63,154 |
| 2023 | 315 | 956 | 75 | 2.35 | $767,060 | $86,215 |
| 2022 | 375 | 1,092 | 74 | 2.42 | $855,441 | $90,404 |
| 2021 | 378 | 1,008 | 74 | 2.41 | $806,281 | $84,402 |
| 2020 | 184 | 569 | 73 | 2.60 | $432,879 | $46,862 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 201 | $48,624 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $12,977 | $126 |
| Hospital discharge day management, more than 30 minutes | 113 | $9,925 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 61 | $6,551 | $58 |
| Critical care, first 30-74 minutes | 33 | $6,358 | $151 |
2022: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 214 | $48,584 | $76 |
| Hospital discharge day management, more than 30 minutes | 126 | $10,268 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $10,055 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $6,444 | $53 |
| Critical care, first 30-74 minutes | 36 | $5,834 | $162 |
| Initial hospital observation care per day, typically 70 minutes | 39 | $5,159 | $132 |
| Advance care planning, first 30 minutes | 13 | $994 | $58 |
| Hospital observation care on day of discharge | 13 | $694 | $53 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 194 | $40,870 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $10,957 | $150 |
| Hospital discharge day management, more than 30 minutes | 116 | $9,682 | $80 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,445 | $53 |
| Critical care, first 30-74 minutes | 31 | $5,339 | $167 |
| Initial hospital observation care per day, typically 70 minutes | 32 | $4,280 | $134 |
| Follow-up observation care per day, typically 35 minutes | 23 | $2,038 | $78 |
| Hospital observation care on day of discharge | 26 | $1,420 | $55 |
| Advance care planning, first 30 minutes | 14 | $894 | $60 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $21,881 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $6,679 | $155 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $6,375 | $55 |
| Hospital discharge day management, more than 30 minutes | 52 | $4,545 | $83 |
| Critical care, first 30-74 minutes | 16 | $2,951 | $164 |
| Advance care planning, first 30 minutes | 15 | $984 | $62 |
| Hospital observation care on day of discharge | 14 | $787 | $56 |
Medicaid work
$9,810 in 2023
Medicaid paid $9,810 for 492 billed services this clinician did in 2023, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 423 | $9,027 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 45 | $489 |
| 1ST HOSP IP/OBS HIGH 75 | 24 | $294 |
| 2023 | 492 | 3 | 23 | $9,810 |
| 2022 | 249 | 1 | 15 | $6,709 |
See the largest Medicaid services in earlier years
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 249 | $6,709 |
Drugs they prescribed that Part D paid
$5,122
Pharmacies billed $5,122 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
119 generic and fewer than 11 brand-name prescriptions · $5,122 in drug cost · 20 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Furosemide | 12 | $33 | $3 |
Year by year
| 2024 | 127 | 63 | None | None | $5,122 |
| 2023 | 231 | 105 | None | None | $12,104 |
| 2022 | 324 | 120 | None | None | $15,635 |
| 2021 | 242 | 117 | None | None | $13,240 |
| 2020 | 688 | 69 | None | 19% | $70,485 |
| 2019 | 983 | 60 | None | 22% | $98,860 |
| 2018 | 842 | 46 | 2% (13) | 23% | $97,178 |
| 2017 | 173 | 25 | None | None | $23,964 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Atorvastatin | 32 | $247 | $8 |
| Metoprolol | 12 | $67 | $6 |
| Pantoprazole | 14 | $57 | $4 |
| Prednisone | 12 | $47 | $4 |
2022: 9 drugs
| Bumetanide | 13 | $833 | $64 |
| Atorvastatin | 30 | $221 | $7 |
| Potassium Chloride | 15 | $189 | $13 |
| Prednisone | 12 | $146 | $12 |
| Pantoprazole | 18 | $106 | $6 |
| Dexamethasone | 11 | $102 | $9 |
| Furosemide | 21 | $73 | $3 |
| Amlodipine Besylate | 14 | $60 | $4 |
| Metoprolol | 16 | $50 | $3 |
2021: 4 drugs
| Dexamethasone | 17 | $106 | $6 |
| Prednisone | 15 | $65 | $4 |
| Furosemide | 12 | $46 | $4 |
| Cephalexin | 13 | $39 | $3 |
2020: 18 drugs
| Levemir Flextouch | 20 | $9,873 | $494 |
| Symbicort | 17 | $6,196 | $364 |
| Ventolin Hfa | 11 | $644 | $59 |
| Albuterol Sulfate Hfa | 13 | $571 | $44 |
| Trueplus Pen Needle | 11 | $269 | $24 |
| Spironolactone | 24 | $253 | $11 |
| Atorvastatin | 53 | $235 | $4 |
| Pantoprazole | 21 | $233 | $11 |
| Allopurinol | 14 | $189 | $13 |
| Gabapentin | 15 | $170 | $11 |
| Amlodipine Besylate | 52 | $115 | $2 |
| Metformin | 40 | $115 | $3 |
| Quetiapine | 14 | $113 | $8 |
| Lisinopril | 36 | $98 | $3 |
| Dexamethasone | 11 | $71 | $6 |
| Furosemide | 23 | $55 | $2 |
| Clopidogrel | 12 | $51 | $4 |
| Losartan | 12 | $38 | $3 |
2019: 31 drugs
| Genvoya | 12 | $36,945 | $3,079 |
| Novolog Flexpen | 17 | $9,466 | $557 |
| Levemir Flextouch | 24 | $8,856 | $369 |
| Janumet | 11 | $4,986 | $453 |
| Ventolin Hfa | 22 | $1,277 | $58 |
| Proair Hfa | 16 | $1,055 | $66 |
| Labetalol | 14 | $735 | $53 |
| Trueplus Pen Needle | 30 | $721 | $24 |
| Atorvastatin | 99 | $688 | $7 |
| Rosuvastatin | 12 | $284 | $24 |
| Fluticasone Propionate | 29 | $216 | $7 |
| Spironolactone | 30 | $201 | $7 |
| Metformin | 46 | $197 | $4 |
| Lisinopril | 41 | $191 | $5 |
| Amlodipine Besylate | 70 | $183 | $3 |
| Hydralazine | 23 | $182 | $8 |
| Propranolol | 12 | $181 | $15 |
| Prazosin | 12 | $167 | $14 |
| Potassium Chloride | 16 | $152 | $10 |
| Pantoprazole | 20 | $146 | $7 |
| Furosemide | 43 | $130 | $3 |
| Warfarin | 12 | $82 | $7 |
| Metoprolol | 11 | $75 | $7 |
| Trazodone | 20 | $70 | $4 |
| Allopurinol | 14 | $60 | $4 |
| Losartan | 24 | $58 | $2 |
| Clopidogrel | 13 | $48 | $4 |
| Ranitidine | 14 | $47 | $3 |
| Hydrochlorothiazide | 15 | $37 | $2 |
| Hydroxyzine | 11 | $35 | $3 |
| Single Use Swab | 12 | $23 | $2 |
2018: 28 drugs
| Genvoya | 12 | $35,741 | $2,978 |
| Novolog Flexpen | 29 | $13,725 | $473 |
| Lantus Solostar | 21 | $7,398 | $352 |
| Spiriva | 18 | $7,273 | $404 |
| Levemir Flextouch | 17 | $4,055 | $239 |
| Ventolin Hfa | 13 | $723 | $56 |
| Oxcarbazepine | 12 | $703 | $59 |
| Atorvastatin | 73 | $692 | $9 |
| Bupropion Hcl Sr | 12 | $608 | $51 |
| Trueplus Pen Needle | 21 | $502 | $24 |
| Labetalol | 18 | $470 | $26 |
| Potassium Chloride | 36 | $445 | $12 |
| Prazosin | 12 | $258 | $22 |
| Lisinopril | 43 | $235 | $5 |
| Amlodipine Besylate | 53 | $234 | $4 |
| Fluticasone Propionate | 22 | $176 | $8 |
| Spironolactone | 23 | $136 | $6 |
| Metformin | 30 | $125 | $4 |
| Warfarin | 13 | $117 | $9 |
| Hydralazine | 12 | $96 | $8 |
| Trazodone | 22 | $78 | $4 |
| Hydroxyzine | 12 | $70 | $6 |
| Clopidogrel | 12 | $60 | $5 |
| Furosemide | 23 | $52 | $2 |
| Ranitidine | 12 | $41 | $3 |
| Hydrochlorothiazide | 13 | $41 | $3 |
| Citalopram Hbr | 11 | $40 | $4 |
| Losartan | 16 | $28 | $2 |
2017: 2 drugs
| Atorvastatin | 12 | $102 | $8 |
| Amlodipine Besylate | 19 | $99 | $5 |
Money from drug and device companies
$57 in 2025
| 2025 | 2 | 3 | None | $57 |
| 2024 | 4 | 4 | None | $89 |
| 2023 | 3 | 3 | None | $48 |
| 2022 | 5 | 5 | None | $279 |
| 2021 | 1 | 1 | None | $125 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $41 | 2 payments
|
| Abbvie | Emblaveo | $16 | 1 payment
|
See all 3 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-09-11 | Lifevest | $22 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-07-10 | Lifevest | $20 |
| Abbvie | Meals · 2025-06-23 | Emblaveo | $16 |
See earlier years (2024, 2023, 2022, 2021)
2024: $89
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $27 | 1 payment
|
| Recor Medical | Paradise Renal Denervation System | $25 | 1 payment
|
| Abbott Laboratories | Amplatzer Amulet | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $13 | 1 payment
|
2023: $48
| Janssen Pharmaceuticals | Xarelto | $18 | 1 payment
|
| AbbVie | Teflaro | $15 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $15 | 1 payment
|
2022: $279
| Eisai | Lenvima | $122 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $91 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $30 | 1 payment
|
| Abbvie | None | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $18 | 1 payment
|
2021: $125
| Alexion Pharmaceuticals | None | $125 | 1 payment
|
Professional record
- NPI
- 1649790486
- Licence
- KS 04-43469
- Group
- Providence Medical Foundation · Hospitalist Medicine Physicians of Texas PLLC
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 6340 Clayton Road, Richmond Heights, MO, 63117
- NPI first listed
- 2017-06-22
- NPI last updated
- 2022-07-29
- NPI record certified
- 2022-07-29
This is when the NPI record was last certified, not a medical board exam.